Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relebactam + Imipenem/Cilastatin in cUTI
NCT01505634Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of relebactam in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Merck & Co.. Started May 2012; status: completed.
02
Drugs
relebactam
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT01505634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505634.